Abstract: An information processing device that executes a program includes: a storage unit that includes a plurality of regions for storing a rewritable program; a calculation unit that executes a program stored in the storage unit; a start region specification unit that specifies, from the plurality of regions, a start region in which the calculation unit is executing a program; a rule update unit that specifies a rewrite target region in which a program can be rewritten based on information on the specified start region; and a reception selection unit that selectively receives a rewrite program stored in the rewrite target region.

Abstract: A power storage material is made by using a fiber material of cellulose molecules obtained from wood, plant fibers (pulp), and the like, and capable of storing electric power of direct current and alternating current, and an ultra power storage body has the power storage material. A power storage material includes a fiber mainly including a fiber derived from at least any one of wood, plant fibers (pulp), animals, algae, microorganisms, and microbial products, and having a large number of recesses and protrusions on a surface. The fiber is preferably crystallized/amorphous fibers, is preferably an amorphous fiber having an atomic vacancy, and preferably has a specific surface area of 10 m2/g or more. Preferably, the large number of recesses and protrusions have a diameter of 1 nm to 500 nm.

Abstract: A resource management apparatus includes a memory and a processor coupled to the memory. The processor is configured to receive a usage of a target virtual machine provided to a user and a request benchmark score requested by the user. The processor is configured to determine first resources to be used for constructing the target virtual machine based on the received usage and request benchmark score. The processor is configured to construct a first virtual machine using the first resources.

Abstract: The present invention relates to heterocyclic derivatives which have blocking activities of voltage gated sodium channels as the Nav1.7 and Nav1.8 channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

Abstract: A vapor cycle compressor includes a motor section and a compression section operatively engaged with the motor section. A refrigerant path is in the motor section and in the compression section. The refrigerant path includes: a compression refrigerant path, for a single phase compression refrigerant, in the compression section; an inner rotor shaft refrigerant path, for a single phase inner rotor shaft refrigerant, in the compression section and in the motor section; and a stator refrigerant path, for a two phase stator refrigerant, in the motor section.

Abstract: The present invention relates to amide derivatives which have blocking activities of voltage gated sodium channels as the Nav1.7 and Nav1.8 channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

Abstract: The present invention relates to biaryloxy derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channel is involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

Abstract: The present invention relates to biaryloxy derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channel is involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

Abstract: An electronic device comprising: a substrate; a first elastic body which is positioned on one surface of the substrate; and a second elastic body which is positioned under the other surface of the substrate and is harder than the first elastic body, wherein the first elastic body and the second elastic body sandwich and hold the substrate.

Abstract: The present invention relates to amide derivatives which have blocking activities of voltage gated sodium channels as the Nav1.7 and Nav1.8 channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

Abstract: A resource management apparatus includes a memory and a processor coupled to the memory. The processor is configured to receive a usage of a target virtual machine provided to a user and a request benchmark score requested by the user. The processor is configured to determine first resources to be used for constructing the target virtual machine based on the received usage and request benchmark score. The processor is configured to construct a first virtual machine using the first resources.

Abstract: A vapor cycle compressor includes a motor section and a compression section operatively engaged with the motor section. A refrigerant path is in the motor section and in the compression section. The refrigerant path includes: a compression refrigerant path, for a single phase compression refrigerant, in the compression section; an inner rotor shaft refrigerant path, for a single phase inner rotor shaft refrigerant, in the compression section and in the motor section; and a stator refrigerant path, for a two phase stator refrigerant, in the motor section.

Abstract: An electronic device comprising: a substrate; a first elastic body which is positioned on one surface of the substrate; and a second elastic body which is positioned under the other surface of the substrate and is harder than the first elastic body, wherein the first elastic body and the second elastic body sandwich and hold the substrate.

Abstract: A power supply device includes: a power supply circuit configured to supply electric power; a signal input-and-output portion to be coupled to a sub board, the sub board including a first load configured to receive the electric power and a voltage range generation circuit configured to generate a voltage range signal indicative of a power supply voltage range of the first load; and an arithmetic circuit configured to compute an output voltage of the power supply circuit based on the voltage range signal which is input via the signal input-and-output portion and first power supply voltage information relating to a first voltage at a first supply terminal of the first load to be supplied with the electric power.

Abstract: The present invention relates to pyrazolopyridine derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

Abstract: An information processing apparatus including a plurality of slots into which a storage device container including a storage device and a first memory that stores first position information representing a slot to which the storage device is to be attached is inserted, a second memory that stores configuration information including second position information representing a slot into which the storage device has been attached, a controller that compares the first position information and the second position information and determines whether or not the storage device has been attached to a slot represented by the first position information, on a basis of a comparison result, and a processor that outputs the first position information when the storage device has not been attached to a slot represented by the first position information.

Abstract: The present invention relates to amide derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

Abstract: The present invention relates to aryl substituted carboxamide derivatives of formula (I) or a pharmaceutically acceptable salt thereof, which have blocking activities of T-type calcium channels or voltage gated sodium channels as the tetrodotoxin-sensitive (TTX-S) blocker such as NaV1.3 and NaV1.7, and which are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels or voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels or voltage gated sodium channels are involved.

Abstract: The present invention relates to arylamide derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

Abstract: A power supply device includes: a power supply circuit configured to supply electric power; a signal input-and-output portion to be coupled to a sub board, the sub board including a first load configured to receive the electric power and a voltage range generation circuit configured to generate a voltage range signal indicative of a power supply voltage range of the first load; and an arithmetic circuit configured to compute an output voltage of the power supply circuit based on the voltage range signal which is input via the signal input-and-output portion and first power supply voltage information relating to a first voltage at a first supply terminal of the first load to be supplied with the electric power.